Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 34,125 | 26,063 | 25,881 | 20,401 | 12,043 |
| Cost of Goods | 1,520 | 1,238 | 12,379 | 1,345 | 1,366 |
| Gross Profit | 32,605 | 24,825 | 13,502 | 19,056 | 10,677 |
| Operating Expenses | 23,810 | 20,920 | 84,920 | 24,763 | 26,459 |
| Operating Income | 9,315 | 4,143 | -71,039 | -5,362 | -15,416 |
| Interest Expense | 1,948 | 2,051 | 2,009 | 1,969 | 2,194 |
| Other Income | 5,299 | -3,069 | 149,954 | 5,414 | -2,758 |
| Pre-tax Income | 12,666 | -977 | 76,906 | -1,917 | -20,368 |
| Income Tax | 501 | -433 | 2,199 | 1,182 | 15,371 |
| Net Income Continuous | 12,165 | -544 | 74,707 | -3,099 | -35,739 |
| Net Income | $12,165 | $-544 | $74,707 | $-3,099 | $-35,739 |
| EPS Basic Total Ops | 0.23 | -0.01 | 1.24 | -0.06 | -0.71 |
| EPS Basic Continuous Ops | 0.21 | -0.01 | 1.36 | -0.06 | -0.71 |
| EPS Diluted Total Ops | 0.21 | -0.01 | 1.21 | -0.06 | -0.71 |
| EPS Diluted Continuous Ops | 0.19 | -0.01 | 1.33 | -0.06 | -0.71 |
| EPS Diluted Before Non-Recurring Items | 1.16 | -0.01 | -0.06 | -0.06 | -0.67 |
| EBITDA(a) | $8,820 | $3,324 | $-11,433 | $-4,018 | $-14,658 |